Breast conserving therapy shows survival benefit compared to mastectomy in early-stage patients with hormone receptor positive disease
When factoring in what is now known about breast cancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone-receptor positive disease, according to research.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Biology | Breast Cancer | Breast Conservation Surgery | Cancer | Cancer & Oncology | Hormones | Mastectomy | Science | Women